One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
A Deep Dive into CapitalBiotech's LuxScan TechnologyFebruary 8, 2024Microarrays have revolutionized the field of life sciences, enabling researchers to analyze thousands of genes simultaneously. This technology underpins advancements in various fields, from drug disco...view
What Is Fetal Chromosomal Aneuploidy Test?April 8, 2024Fetal chromosomal aneuploidy testing analyzes a developing baby's chromosomes to identify any abnormal numbers. Chromosomes are the thread-like structures within cells that carry our genetic infor...view
16S vs 18S vs ITS SequencingMarch 7, 2024CapitalBio, a leader in microbiome research, delves into the fascinating world of microbial identification through 16S, 18S, and ITS sequencing technologies. This article explores these techniques to ...view